N Sarlet

A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss

Jean‐Yves Reginster, Rita Deroisy, Marie P. Lecart et al. · The American Journal of Medicine · 1995 · 89 citations

Medicine, Endocrinology, Pharmacotherapy +12

Minimal levels of serum estradiol prevent postmenopausal bone loss

Jean‐Yves Reginster, N Sarlet, Rita Deroisy et al. · Calcified Tissue International · 1992 · 71 citations

Medicine, Endocrinology, Gynecology +14

Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin

J.-Y. Reginster, D. Denis, Rita Deroisy et al. · Journal of Bone and Mineral Research · 1994 · 68 citations

Medicine, Endocrinology, Nutrition +15

Strontium ranelate: A new treatment for postmenopausal osteoporosis with a dual mode of action

Jean‐Yves Reginster, N Sarlet, Eric Lejeune et al. · Current Osteoporosis Reports · 2005 · 34 citations

Medicine, Endocrinology, Bone Metabolism +13

THE EFFECT OF NASAL hCT ON BONE TURNOVER IN PAGET'S DISEASE OF BONE—IMPLICATIONS FOR THE TREATMENT OF OTHER METABOLIC BONE DISEASES

Jean‐Yves Reginster, A.M. Jeugmans-Huynen, Murielle Wouters et al. · Lara D. Veeken · 1992 · 22 citations

Medicine, Pharmacology, Pharmacotherapy +17